Yu Alice Lin-Tsing 4

What Happened Yu Alice Lin-Tsing, a director of OPKO Health, was granted 30,000 shares as an award (transaction code A) on 2026-06-18. The Form 4 lists the acquisition price as $0.00 and reports the shares as a derivative acquisition (typical for stock awards or RSUs converting to common stock). This was a grant/compensation event rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-18; Form 4 filed: 2026-06-22 (filed within the usual 2-business-day window).
• Security: Common stock acquired via award (derivative), 30,000 shares, $0.00 per share; total shown value $0 on the Form 4.
• Post-transaction holdings: Not specified in the provided filing details.
• Notes: Code A denotes an award/grant. Such awards are often subject to vesting or other plan conditions; the Form 4 does not detail vesting or tax-withholding information.

Context An award of shares is compensation rather than a market purchase and does not necessarily indicate immediate buying/selling intent. For retail investors, grants can reflect company compensation practices; they should not be interpreted alone as a bullish or bearish signal.